NDC properties for "teniposide 50 MG per 5 ML Injection" (RxCUI 313213)
About this data
The tables show NDC propoerties for teniposide 50 MG per 5 ML Injection with the RxCUI 313213
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for teniposide 50 MG per 5 ML Injection (RxCUI 313213)
| MMSL_CODE | BD3277 |
|---|---|
| MMSL_CODE | CD3277 |
| RxCUI | 313213 |
| SNOMEDCT | 785019000 |
| VUID | 4010255 |
| VUID | 4010256 |
| Prescribable Synonym | teniposide 50 MG in 5 ML Injection |
| RXNAV_STR | 5 ML teniposide 10 MG/ML Injection |
| RxNorm Name | 5 ML teniposide 10 MG/ML Injection |
| RxNorm Synonym | teniposide 50 MG per 5 ML Injection |
| Related queries | Interactions (for RxCUI 313213) |
NDC Properties
NDC Item 44567050701
| NDC 9 | 44567-507 |
|---|---|
| NDC 10 | 44567-507-01 |
| NDC Item | 44567050701 |
| Packaging | 1 AMPULE in 1 CARTON (44567-507-01) / 5 mL in 1 AMPULE |
| FDA SPL set id | 420543 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2018-07-31 |
| Marketing effective time low | 2013-04-30 |
| Marketing status | COMPLETED |
| NDA | NDA020119 |
| Related queries | Properties for NDC 9 44567-507 |